Health-related Quality of Life and Comorbidities in Danish Patients With Idiopathic Pulmonary Fibrosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-08-31

Study Completion Date

2021-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with a high mortality. Health-related quality of life (HRQL) is impaired in patients with IPF. Little is known about the properties of recently developed HRQL questionnaires and about the longitudinal changes in HRQL, including factors with an impact on HRQL. Comorbidities have an impact on patients with IPF, but reports differ in incidence and prevalence. The impact of comorbidities on HRQL and disease progression has only been studied sparsely. Also, the association between biomarkers and disease progression need to be examined further.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Quality of Life in IPF - Patient and Physician Perceptions

NCT04148157

Idiopathic Pulmonary Fibrosis

COMPLETED

Immunopathologic Profiles and Blood Biomarkers in Patients With IPF

NCT04187079

Idiopathic Pulmonary Fibrosis

COMPLETED

Health and Quality of Life Assessment Project for Caregivers of Idiopathic Pulmonary Fibrosis Patients

NCT04031690

Idiopathic Pulmonary Fibrosis Patient-caregiver Dyads

COMPLETED

Modelling of Quality Life, Clinical and Physiological Measures in Idiopathic Pulmonary Fibrosis

NCT02176707

Idiopathic Pulmonary Fibrosis Dyspnoea Anxiety +1 more

UNKNOWN

Disease-syndrome Characteristics of IPF

NCT07178392

Idiopathic Pulmonary Fibrosis (IPF)

NOT_YET_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Idiopathic Pulmonary Fibrosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with IPF

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. A clinical diagnosis of IPF
2. Signed informed consent

Exclusion Criteria

1. Clinical, radiological or histological findings inconsistent with a diagnosis of IPF
2. Inability or unwillingness to adhere to the study
3. Active on lung transplantation list

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No